Articles tagged with Mutation
Researchers found that new mutations, separate from inherited mutations, significantly contribute to the occurrence of schizophrenia. This discovery highlights the significance of personal genome sequencing in understanding complex diseases like schizophrenia.
Researchers have found that de novo protein-altering mutations account for more than 50% of sporadic schizophrenia cases. These genetic errors are present in patients but not in their parents. The study suggests that many more mutations may contribute to the disease, paving the way for new treatments.
Scientists have identified a rare genetic mutation that underlies adermatoglyphia, a condition characterized by the complete absence of fingerprints. The study provides valuable insight into the genetics of fingerprint formation and highlights the usefulness of rare genetic mutations in understanding human biology.
Researchers discovered genetic changes in the mitochondrial genome of iPS cells, which can cause metabolic disorders and nervous diseases. The study highlights the need to test cell lines intended for clinical use for such mutations.
Mutations in MSR1, ASCC1, and CTHRC1 genes are linked to increased risk of esophageal adenocarcinoma and Barrett esophagus, a premalignant condition caused by chronic GERD. The study found that these three genes accounted for 11 percent of cases, highlighting the potential importance of genetic testing in risk assessment.
Researchers have identified genetic mutations in patients with Barrett's esophagus and esophageal adenocarcinoma, linking a heritable cause to the disease. Three genes, MSR1, ASCC1, and CTHRC1, were found to be mutated in 11% of BE/EAC patients, suggesting a significant genetic predisposition.
Researchers have identified detectable changes in biological markers in the spinal fluid up to 20 years before dementia onset. Participants with inherited Alzheimer's mutations exhibit lower amyloid beta and higher tau protein levels in their cerebrospinal fluid, indicating potential for prevention trials.
Researchers at Mayo Clinic discovered a genetic mutation in VPS35 that causes Parkinson's disease, leading to protein buildup in the brain. This finding opens up new avenues for understanding and treating the complex disease.
Researchers discovered seven new genes linked to Ankylosing Spondylitis, bringing the total to thirteen known predisposing genes. The study also revealed an interaction between genetic mutations HLA-B27 and ERAP1, providing insight into the disease's cause.
Researchers at Brigham and Women's Hospital developed a method to predict MDS patient survival by identifying specific gene mutations in their abnormal bone marrow. Nearly a third of patients had mutations in one or more prognostic genes, which could guide treatment decisions.
A study by Massachusetts General Hospital researchers reveals that disruption of the molecular pathway causing Gaucher disease leads to toxic α-synuclein deposits in Parkinson's disease. This finding indicates therapies targeting this pathway may be a new option for patients with Parkinson's disease.
A research team has identified the disease-causing mutation in a newly characterized rare genetic disease using DNA from just a few individuals. The VAAST tool, developed by Mark Yandell and Martin G. Reese, uses rapid and accurate gene-sequencing techniques to pinpoint mutations in individual patients.
Researchers from the University of Pittsburgh and UW-Madison traced how a specific gene became activated in optical neurons of a fruit fly species over four mutations. They found that small alterations in transcriptional enhancers caused 'leaky' gene activity, leading to the development of a new trait.
Researchers have discovered new gene mutations in CLL patients, linking NOTCH1 pathway to poorer prognosis and shorter survival. The findings suggest the potential for diagnostic and therapeutic purposes in human CLL.
Research suggests that many hereditary conditions are linked to errors in pre-mRNA splicing, which can be addressed through new therapies. A computer analysis predicts that 22 percent of genetic mutations may affect splicing, implying hundreds of hereditary diseases could be linked to this issue.
Researchers have discovered a chromosomal mutation responsible for a very rare condition called CGH, which causes individuals to grow excess hair on their bodies. The study found that the insertion of chromosome 5 into the X chromosome appears to turn on a gene, likely SOX3, leading to excessive hair growth.
Scientists at the University of Washington have identified 21 newly occurring genetic mutations in children with autism spectrum disorder, many of which altered proteins. The study suggests that these sporadic mutations could contribute substantially to the underlying mechanisms and severity of autism in approximately 20 percent of cases.
A study by MIT researchers calculated the likelihood of a particular evolutionary adaptation reversing itself. They found that only a small percentage of evolutionary adaptations in drug-resistance genes can be reversed, but only if they involve fewer than four discrete genetic mutations.
Scientists have identified a single amino acid change in the chikungunya virus' exterior protein that enables it to infect Aedes albopictus mosquitoes, allowing for rapid spread across India and Southeast Asia. The discovery sheds light on why outbreaks occurred despite previous strains being present in the region.
Researchers identified a genetic mutation causing fatal developmental disease MOPD1, affecting fetal growth and brain development. The mutation is prevalent in the Ohio Amish population, with approximately 6% prevalence.
Researchers at Vanderbilt University identified a new gene, KCNV2, that influences the risk of developing epilepsy. The gene codes for a unique potassium channel protein and alters electrical activity in nerve cells, leading to seizures.
A study of pregnant women with autoimmune diseases found specific genetic mutations associated with preeclampsia. The research suggests new genetic targets for treatment and potential tests to identify women at risk of developing the condition.
Brown University researcher Robert Reenan has created mutant fruit flies that mimic human epilepsy, with the goal of finding genes that can suppress seizures. By using a unique technique called homologous recombination, Reenan hopes to induce mutations in the flies that may lead to a genetic cure for epilepsy.
Researchers found a genetic mutation caused by vitamin A that suppressed feather growth, leading to the distinctive naked neck appearance. This discovery has implications for understanding bird evolution and could improve poultry production in hot climates.
A complex genetic mutation triggered by a vitamin A-derived substance caused the development of bald necks in Transylvanian naked neck chickens. The mutation led to enhanced production of an inhibitory protein called BMP12, resulting in an outstanding bald neck.
Researchers at MIT have identified a single mutation in the H1N1 genetic makeup that would allow it to be much more easily transmitted between people. The finding should give the World Health Organization something to watch out for, as new strains of the virus may emerge with greater ability to infect humans.
Researchers identified a dominant Indo-European mutation in Spain and its spread to America, linked to high prevalence on La Palma and Brazil. The study mapped over 130 pathogenic mutations, revealing the mutation's impact on DNA repair pathways and cancer risk.
Researchers found a rare genetic glitch in patients with schizophrenia that could lead to improved treatments. The VIPR2 gene mutation was linked to overactive VIP activity, which can impact brain development and learning, offering potential targets for new therapies.
Researchers developed a new approach to predict which flu strain will be prevalent in a given year by tracking pairs of genetic changes. This method offers insights into epistasis, where mutations interact with each other to affect the virus's fitness. By analyzing these interactions, scientists can gain early warnings of emerging muta...
Researchers found that two genetic mutations can trigger hypertension in severe cases, affecting up to one-third of patients with a common cause. The mutations affect potassium channels and aldosterone release, leading to adrenal tumor formation and severe high blood pressure.
Researchers have found a genetic cause for benign hormone-producing tumours in the adrenal gland that lead to high blood pressure. The mutation affects a potassium channel, resulting in excessive aldosterone production and elevated blood pressure.
Long QT syndrome affects approximately 1 in 2500 people and can cause torsade de pointes episodes leading to sudden death. Researchers identified KCNH2 as the most frequent mutation in patients with long QT syndrome, highlighting the potential for genetic testing to diagnose the condition in carriers without symptoms.
A Mayo Clinic research team has pinpointed the function of the MMSET gene, revealing how it enables disease-causing mutations to occur. Normally-functioning MMSET plays a restorative role within the genome, but when impaired, cells lose the correct response to DNA damage.
Researchers at Mayo Clinic have identified a gene variant that appears to protect against frontotemporal lobar degeneration (FTLD) in high-risk individuals with progranulin mutations. The study found that carrying two copies of the protective TMEM106B allele delays or prevents FTLD onset, suggesting it may increase progranulin levels.
A study of 61 adults found that 86.9% of parents with a genetic mutation supporting melanoma testing in their children cited increased risk awareness as a reason. Participants believed genetic testing could lead to improved prevention and screening behavior, such as reduced sun exposure and protective clothing use.
A new study identifies a previously unrecognized mutation in the valosin-containing protein (VCP) gene, which causes an inherited form of amyotrophic lateral sclerosis (ALS). The research provides new insight into the disease's underlying pathology and validates the exome sequencing technique for identifying genetic causes.
Researchers have identified genetic mutations associated with elevated PSA levels in men diagnosed with prostate cancer, offering potential new biomarkers for disease monitoring. The study's findings suggest that sequencing of selected mitochondrial regions could provide valuable information for prognosis.
Scientists at Johns Hopkins have identified a glutaminase inhibitor that slows cancer cell growth by blocking the sugar-based building blocks. The compound has shown promise in reducing cancer cell growth by 30% and may be used for many types of primary brain tumors.
Researchers developed a comprehensive genetic test that can screen all 54 known deafness-causing genes in one run, costing $2,000. The new OtoSCOPE test offers quicker answers for families anxious to determine treatment options or learn the likelihood of future children having hearing loss.
A study has identified two key signaling pathways - Ras/MAPK and Rac/Stat3 - that are activated in the hearts of mice with a Noonan syndrome-associated Sos1 mutation. These pathways may be crucial for understanding the development of heart defects in individuals with the disorder.
Newfoundland researchers have cracked the genetic code of arrhythmogenic right ventricular cardiomyopathy (ARVC), a rare genetic condition causing sudden cardiac death. The team developed an implantable cardiodefibrillator program to prevent fatal arrhythmic events, significantly improving survival rates among high-risk individuals.
A genetic mutation in the production of selenocysteine leads to progressive brain atrophy and severe mental retardation and epilepsy. The defect affects 1 in 40 Jews of Moroccan and Iraqi ancestry, making prenatal genetic screening a crucial preventive measure.
University of Oregon researchers discovered that good bacteria modulate the Wnt signaling pathway, which is also associated with colorectal cancer. This finding suggests that microbial signals may play a significant role in cancer risk, and targeted therapy may be possible.
An Australian study discovered a rare genetic form of epilepsy can originate from an embryonic genetic mutation, challenging previous assumptions about its inheritance. Researchers believe this finding may have implications for siblings of individuals with other genetic diseases that could be caused by an embryo mutation.
Researchers identified a defective ABCB4 gene that impairs cholesterol excretion, leading to high levels of bad cholesterol. The study used laboratory opossums and found that the gene plays a role in controlling blood cholesterol levels in response to dietary cholesterol.
The NCAA's new sickle cell screening program for college athletes aims to prevent rare complications, but experts warn of hasty implementation and unaddressed consequences. The program may identify 400-500 new cases annually, affecting nearly 170,000 athletes.
Scientists at Max Planck Institute successfully analyze all genes in human genome simultaneously to identify mutation causing Mabry Syndrome. The new process reveals a mutation in PIGV gene leading to mental retardation and other symptoms.
Researchers identify a genetic mutation in the immune system causing chronic kidney disease in Cypriot families, with symptoms including blood in the urine and progressive kidney malfunction. The mutation dates back to a single common ancestor over 16 generations ago.
Researchers have identified a rare form of kidney disease linked to a genetic mutation in the innate immune system, causing progressive kidney malfunction and blood in urine. The condition, named CFHR5 nephropathy, has been found in over 100 people of Cypriot descent and is potentially serious but can be detected through DNA testing.
A new statistical method confirms that mitochondrial Eve, the mother of all humans, lived around 200,000 years ago. The study compared 10 human genetic models and found that they produced similar estimates, suggesting that refining assumptions beyond a certain point is not crucial in capturing the big picture.
Researchers have identified a novel mutation in a mouse gene that may contribute to the genetic roots of alcoholism. The mutation, called Lightweight, affects sensitivity to alcohol and voluntarily consumed more alcohol by mutant mice. Further studies are needed to determine if this pathway is relevant to humans.
A UCSF-led team has discovered a direct link between an inherited genetic mutation, developmental abnormalities, and juvenile myelomonocytic leukemia (JMML), a rare form of childhood cancer. The study found that germline CBL mutations are inherited in nearly half the families affected by JMML.
Researchers have discovered two mutations in the PTPN11 gene that cause metachondromatosis, a rare heritable disease. The study's findings suggest that next-gen sequencing may rapidly resolve familial diseases and provide insights into other related syndromes.
A research team at McGill University Health Centre has developed a rapid genome sequencing process to identify genetic diseases, promising personalized treatments for patients. The new approach can isolate genes responsible for hereditary diseases within two weeks, revolutionizing the screening and treatment of genetic disorders.
Researchers at the University of Pittsburgh have discovered a genetic mutation linked to lymphatic dysfunction, which could lead to a first-ever target for drug therapy for lymphedema. The study identified mutations in the GJC2 gene that impair cell signaling, leading to fluid accumulation and tissue swelling.
Researchers at Heidelberg University Hospital have identified new mutations in the SHANK2 gene that contribute to autism and mental retardation. The study found that a correct inner structure of nerve cell synapses is necessary for normal language, social competence, and cognitive development.
A new study has uncovered two more genes associated with autism, furthering evidence of the disorder's genetic foundation. The research also suggests that environmental factors may play a role in the development of autism in susceptible individuals.
A new experimental drug called ataluren has shown promise in treating cystic fibrosis and over 2,400 genetic disorders caused by nonsense mutations. The drug works by restoring up to 29% of normal protein function in mice with cystic fibrosis, offering hope for improved treatment options.
Researchers have made significant progress in treating inherited diseases by suppressing DNA mutations, with a promising experimental drug ataluren showing potential for cystic fibrosis treatment. The drug's selectiveness offers hope for targeting specific disease-causing mutations while sparing healthy genes.
Researchers have discovered a genetic mutation associated with motor neurone disease that causes proteins to clump together in motor neurones, leading to their death. The new finding provides strong evidence for protein aggregation as the underlying cause of MND.